Summary. The prevalence of trimethoprim resistance in enterobacterial urinary pathogens from hospitalised patients in the Angus district of northern Scotland (22.8 YO) was twice that found in similar isolates from patients attending general practitioners (1 1-2 YO). Thirty-three of the 143 trimethoprim-resistant strains were shown to harbour transferable plasmids conferring high-level trimethoprim resistance. In total, 17 different plasmid types were distinguished. Two plasmids, pUK1184 and pUK1185, accounted for 36% of the trimethoprim resistance plasmids and were shown by restriction endonuclease digestion fingerprints to be closely related to plasmid pUK28, previously demonstrated to be endemic in urinary pathogens in the Edinburgh area. Only 21 Yo of the plasmids were shown to encode the type Ia trimethoprim-resistant dihydrofolate reductase, whereas 70 % of the trimethoprim resistance plasmids were found to encode the type Ib dihydrofolate reductase. Hybridisation of the trimethoprim resistance plasmids identified in this study with gene probes specific for the integrase genes of transposons Tn7 and Tn21 indicates that the dhfrIa is rarely present within Tn7 or related transposons in these plasmids and may be more prevalent within Tn21-like transposons. In contrast, with the exception of the two endemic plasmids that harboured the dhfrIb gene within a Tn7-like transposon, the majority of dhfrIb genes were not found to be associated with either Tn7-or Tn21-like structures.
Introduction
Trimethoprim, both alone and in combination with sulphamethoxazole, continues to be used widely for the treatment of urinary tract infections. Resistance to trimethoprim is most commonly mediated by plasmidor transposon-encoded dihydrofolate reductase (DHFR) enzymes which are insusceptible to the inhibitory action of trimethoprim.' To date, a total of 16 different gram-negative bacterial plasmid-encoded DHFRs have been
The type Ia DHFR, commonly carried within the highly successful transposon Tn7,6 is generally reported to account for the majority of high-level trimethoprim re~istance.~ Four other trimethoprim-resistant DHFRs, types Ib, V, VI and VII, share > 60 YO DNA sequence homology with each other and the type la DHFR.',' The epidemiology of each of these genes is less well defined. The dhfrV and 1/11 genes have been reported to occur in bacteria isolated in Europe but at a relatively low frequency.lO-" The dhfr V gene was also identified as the major mediator of plasmid-encoded trimethoprim resistance in enterobacterial isolates from Sri Lanka.13 The dhfrla, V and VII genes have all been identified within integron structures commonly associated with Tn21-like transposons.8*14* l5 The dhfr VI gene has so far been identified exclusively within pathogens isolated in South Africa. 16 The dhfrIb gene, which has been shown to reside within a Tn7-like transposon, Tn4132,' was originally identified within plasmids extracted from urinary pathogens isolated in Edinburgh, Scotland." Recently, this gene has been shown to be present in gram-negative commensal faecal flora obtained from healthy individuals in Southern India."
In Scotland, several surveys have been conducted on both hospital and general practice isolates. These studies have been restricted to two major cities in the South of Scotland, Edinburgh and G l a s g o~. " -~~ As in other parts of Europe, the incidence of plasmidmediated resistance has decreased in both these areas during the 1980~.'"'~ However, amongst the plasmidmediated trimethoprim resistance, one particular resistance plasmid (R-plasmid), pUK28, was found to dominate and has persisted within hospital isolates, especially in the Edinburgh area.", 2o This plasmid belongs to an unusual incompatibility group, IncA, harbours a Tn7-like transposon carrying trimethoprim and streptomycin/spectinomycin resistance determin- ants and a Tn3-like transposon carrying ampicillin resistance determinants. Resistance to sulphamethoxazole is also mediated by pUK28."
The purpose of the present study was to investigate the prevalence and nature of resistance to trimethoprim in urinary pathogens isolated in the Angus district of northern Scotland and to determine whether plasmid pUK28 was also responsible for plasmidmediated trimethoprim resistance in this area.
Materials and methods

Isolutiori of clinical strains
Enterobacterial isolates were cultured from midstream urine specimens containing 10' organisms/L as well as pus cells. They were collected from the diagnostic laboratory, Stracathro Hospital, Angus, between November 1987 and January 1988. All repeat specimens were excluded from the study.
Churuc t er isar ion and sensit it1 it?-testing
Each isolate was identified to genus level by the MAST ID 15 system (Mast Laboratories Ltd, Merseyside). The minimum inhibitory concentration (MIC) of trimethoprim for each organism was determined by diluting a 6-h broth culture in saline 0.9 YO and plating c'. 40-1OOcfu on to the surface of IsoSensitest Agar plates (Oxoid) containing increasing concentrations of trimethoprim. The lowest concentration showing no visible growth after incubation for 18 h at 37°C was taken as the MIC. The sensitivity of each strain was also tested against a selection of antibacterial drugs by plating a similar dilution on to IsoSensitest agar plates containing 10mg/L of drug, except in the cases of sulphamethoxazole and spectinomycin where 100 mg/L was used. The concentrations were chosen so that a direct comparison could be made with our earlier studies in Edinburgh, Glasgow and elsewhere.
Trunsfer-qf' resistance plasrnids
Bacterial strains resistant to trimethoprim 10 mg/L were tested for their ability to transfer trimethoprim resistance by the method described previously. l9 Conjugation studies were performed at both 37°C and 30°C to allow detection of temperature-sensitive transferable plasmids. Escherichia coli K,, strains 553-2 (Fpro met rifampicin-resistant) and 562-1 (F-pro his trp nalidixic acid-resistant)'3 were employed as recipients. The X' transfer factor" was employed for mobilisation of non-self-transferable plasmids by a triple mating procedure described p r e v i o u~l y .~~ Preparation of plasmid DNA and restriction enzyme analysis Plasmid DNA was extracted from overnight nutrient broth cultures by the method of Birnboim and Doly" modified as described by Maniatis et a1. 26 Plasmid DNA was digested with the restriction endonuclease Hind111 (Life Technologies Ltd, Paisley) according to the manufacturer's instructions. Routinely, reaction mixtures contained 10 pl of plasmid DNA and 5-10 units of enzyme in a total volume of 20 pl-Incubation was for 1-2 h at 37°C. DNA fragments were analysed and their sizes were estimated by horizontal agarose gel electrophoresis.
Bacteriophage A DNA, digested with an appropriate. restriction endonuclease, was included on each gel to provide mol. wt standards.
Preparation of Southern blots and D N A h-ybridisation procedures
Plasmid DNA isolated on agarose gels was depurinated, denatured, neutralised and transferred to Hybond N + filters (Amersham International) by the method of Southern." The filters were baked at 80°C for 2 h to immobilise the plasmid DNA before hybridisation. Oligonucleotide probes specific for the dhfrla, Ib, V and VII genes (table I) the conditions recommended by the manufacturer. Pre-hybridisation and hybridisation were performed at 60°C with hybridisation buffers recommended by Amersham. After hybridisation, filters were washed according to the manufacturer's recommendations and detection of a positive hybridisation result was by means of an ECL detection kit (Amersham) with the conditions and protocols recommended by the manufacturer.
Results
Characterisation of clinical strains
Eight hundred and forty-five strains of Enterobacteriaceae were isolated from specimens with significant bacteriuria during the period of study; of these, 417 strains were obtained from hospitalised patients and 428 from patients in the community. Escherichia coli comprised 74.7% of the total population studied ; no significant difference was observed between the two populations. Proteus spp. were more prevalent amongst hospital isolates (1 5.9 YO) than amongst community isolates (9-1 YO). Klebsiella and Enterobacter spp. comprised c. 4 % and 3% of the population, respectively, in both hospital and community isolates; 6 YO of the isolates did not belong to any of these genera.
Each isolate was tested for resistance to a range of antimicrobial agents and the results are summarised in the figure. As expected, the prevalence of resistance to all antimicrobial agents was lower in isolates obtained from general practice than in those obtained from hospitalised patients. resistance (MIC > 10 mg/L) in hospital isolates (22.8 %) was double that found in community isolates (1 1.2 Yo). Similarly the prevalence of spectinomycin resistance within hospital isolates (14.3 YO) was significantly higher than that found in community isolates (4.9%) and may indicate an increased prevalence of Tn7-like transposons, which encode resistance to streptomycin/spectinomycin in addition to trimet hoprim resistance.
Characterisation of trirnethoprirn-resistant isolates
The prevalence and nature of trimethoprim resistance within the two populations is summarised in table 11. In both populations, E.coli accounted for > 70 % of the strains studied. Proteus spp. accounted for 16 YO of the hospital isolates. In contrast, only 9-1 O h of general practice isolates belonged to this genus. However, the increased incidence of Proteus spp. among hospital specimens did not contribute to the different overall level of trimethoprim resistance observed in the two populations. The majority of trimethoprim-resistant bacteria were found to be resistant to 1000 mg/L (77.9 YO of trimethoprimresistant hospital isolates and 8 1.2 YO of general practice isolates).
Each isolate resistant to 10 mg/L of trimethoprim was tested for the presence of transferable R-plasmids. The results (table 11) show that only 23% of the resistant strains in each population transferred trimethoprim resistance. Three of the plasmids identified in hospital isolates, and one plasmid from a general practice isolate, required to be mobilised by the X+ transfer factor. In addition, one plasmid, from a general practice specimen, transferred only at the lower temperature of 30°C. All the trimethoprim Rplasmids mediated resistance to high levels of the agent (MIC > 1000 mg/L).
Characterisation of R-plasrnids
The 33 trimethoprim R-plasmids (22 from hospital isolates and 11 from general practice isolates) were characterised by determination of their resistance profile, molecular size and Hind111 restriction endonuclease fingerprint. Seventeen different plasmid types were distinguished ; eight were found exclusively within the hospital strains (table 111) and five exclusively within the community isolates (table IV). Four plasmids, pUK 1 185, pUK 1 187, pUK 1 189 and pUKll90, were found in both hospital and community isolates.
In the hospital isolates, two plasmids, pUKll84 (identified on six occasions) and pUKll85 (identified on five occasions), were found to predominate. Both plasmids harbour resistance genes for ampicillin, sulphamethoxazole and streptomycin/spectinomycin in addition to trimethoprim. Digestion of plasmid pUKll84 with the restriction endonuclease Hind111 resulted in a fingerprint identical to that obtained after Hind111 digestion of plasmid pUK28, previously shown to predominate in urinary pathogens isolated in Edinburgh hospitals during [1981] [1982] [1983] [1984] [1985] [1986] .'' Plasmid pUK 1 185 showed a very similar restriction pattern, differing only in a single fragment. Plasmid pUKll85 was also found on one occasion in a general practice isolate. In all instances where plasmid pUKll85 was isolated, the host organism was identified as E. coli. Four of the five E. coli strains harbouring pUKl185 were isolated from different patients resident in the same ward of a long-stay hospital, suggesting that resistance in this ward was being spread by crosscontamination with a plasmid-bearing E. coli. In contrast, plasmid pUK 1 184 was identified in clinical strains of E. coli, Citrobacter and Proteus spp. Furthermore, the isolates were obtained from patients in four different hospitals, ruling out the possibility of cross-contamination with a resistant pathogen or Rplasmid.
Characterisation of the trimethoprim resistance genes
Southern blots of the trimethoprim R-plasmids were hybridised with oligonucleotide probes specific for the type Ia, Ib, V and VII DHFR genes. The results aFe summarised in tables I11 and IV. None of the plasmids hybridised with probes specific for the dhfr V and VIZ genes. A total of seven plasmids hybridised with the dhfrIa oligonucleotide probe representing six different plasmid types. Twenty-three plasmids, representing nine different plasmid types and including the two endemic plasmids, pUKll84 and pUKll85, hybridised with the dhfrlb oligonucleotide probe. Three plasmids did not hybridise with any of the DHFR specific probes tested.
Prevalence of Tn7 and Tn21 integrase genes in trimethoprim R-plasmids
Each plasmid was tested for the presence of the int, 
Discussion
The prevalence of trimethoprim resistance amongst urinary pathogens appears to vary according to country. Most recent data indicate that trimethoprim resistance in enterobacterial urinary pathogens in northern Europe has levelled to around 12 % in general practice isolates and 15-20 YO in hospital isolates., In contrast, surveys in tropical and developing countries have revealed that the prevalence of resistance to trimethoprim is very much higher than in industrialised countries, with 3 0 4 4 % of urinary pathogens showing resistance to trimethoprim 10 rng/L., In most areas of the world, the proportion of high-level, nontransferable resistance increased dramatically in the 1980s and this has been shown to result from the migration of trimethoprim resistance genes, carried on resistance transposons, into the bacterial chromo~o m e . l~-~l
The results of this study show that resistance to trimethoprim continues to present a significant dilemma in the choice of treatment for urinary tract infections in Scotland. As might be expected, a notable difference was observed between the prevalence of resistance amongst hospital isolates than amongst those from general practice. In Scotland, studies conducted in Edinburgh during the 1980s showed that following a peak incidence of 18-3 YO trimethoprim resistance (MIC > 10 mg/L) amongst hospital isolates of urinary pathogens, the incidence of resistance to trimethoprim gradually decreased to around 12 YO by 1984 and has remained at that level Resistance levels in the Angus district of northern Scotland are significantly higher than in Edinburgh, although as has previously been reported in clinical strains in Edinburgh and Glasgow, the majority of the highly resistant isolates were unable to transfer their re~istance,l~-~l suggesting that a similar migration of trimethoprim resistance transposons into the bacterial chromosome has occurred in northern Scotland.
An examination of the trimethoprim R-plasmids identified in this survey has revealed that two very closely related R-plasmids, pUKll84 and pUKll85, were responsible for the majority of transferable trimethoprim resistance in this population. Both plasmids are clearly related to plasmid pUK28, the trimethoprim R-plasmid previously shown to be endemic in Edinburgh hospital and community isolates,lg~ 2o and illustrate the epidemic spread and persistent maintenance of a single plasmid within bacterial populations separated by relatively large geographic distances. Plasmid pUK28 was also confirmed in this study to harbour a dhfrZb gene. Hence it would appear that this gene, and not the dhfrIa gene, is the dominant trimethoprim resistance gene amongst trimethoprim R-plasmids in Scotland. Although the dhfrIb gene was found to be present within Tn7-like structures on three occasions, the majority of dhfrIb genes do not appear to be associated with integron structures. Thus, other mechanisms of spread of this gene, which have contributed to its widespread occurrence in trimethoprim R-plasmids in Scotland, must exist and remain to be determined.
